Home » Topics » Regulatory » Patents

Patents
RSS

Fibrinogen receptor antagonists under development at E. Merck

Jan. 10, 1997

No Comments

Merck & Co. describes avermectin analogue

Jan. 10, 1997

No Comments

Thrombin-binding anticoagulant disclosed by Japanese scientists

Jan. 10, 1997

No Comments

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Jan. 9, 1997

No Comments

Potential HIV-1 therapy disclosed by Houghten

Jan. 9, 1997

No Comments

KGF receptor antagonists developed by U.S. researchers

Jan. 9, 1997

No Comments

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

No Comments

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

No Comments

Galderma develops novel compounds active on cell differentiation and proliferation

Jan. 9, 1997

No Comments

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Patents
RSS

Fibrinogen receptor antagonists under development at E. Merck

Merck & Co. describes avermectin analogue

Thrombin-binding anticoagulant disclosed by Japanese scientists

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Potential HIV-1 therapy disclosed by Houghten

KGF receptor antagonists developed by U.S. researchers

High-affinity inhibitor of biogenic amine transporters described

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Galderma develops novel compounds active on cell differentiation and proliferation

Hoechst Japan describes immunosuppressive peptides

Today's news in brief

Today's news in brief

In muscular dystrophies, gene therapies race the clock

Bridgebio, with FDA approval, faces Pfizer in ATTR

‘Evo’ AI can design complete genomes

Patents RSS

Patents
RSS